[S18★☆] Recent trends and future perspectives for non-clinical pharmacokinetics and safety evaluation of therapeutic monoclonal antibodies —at the dawn of a new era

1:59 PM - 2:22 PM JST(4:59 AM - 5:22 AM UTC)

[S18-3] Preclinical DMPK research on next-generation engineered antibodies

○Kenta Haraya¹ (1. Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.